GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soiken Holdings Inc (TSE:2385) » Definitions » Net Current Asset Value

Soiken Holdings (TSE:2385) Net Current Asset Value : 円232.41 (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Soiken Holdings Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Soiken Holdings's net current asset value per share for the quarter that ended in Mar. 2024 was 円232.41.

The historical rank and industry rank for Soiken Holdings's Net Current Asset Value or its related term are showing as below:

TSE:2385' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.7   Med: 2.07   Max: 5.8
Current: 0.7

During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Soiken Holdings was 5.80. The lowest was 0.70. And the median was 2.07.

TSE:2385's Price-to-Net-Current-Asset-Value is ranked better than
92.6% of 1027 companies
in the Biotechnology industry
Industry Median: 3.88 vs TSE:2385: 0.70

Soiken Holdings Net Current Asset Value Historical Data

The historical data trend for Soiken Holdings's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Soiken Holdings Net Current Asset Value Chart

Soiken Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 158.18 200.31 221.39 242.94 256.06

Soiken Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 257.96 256.06 232.09 236.09 232.41

Competitive Comparison of Soiken Holdings's Net Current Asset Value

For the Biotechnology subindustry, Soiken Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Soiken Holdings's Price-to-Net-Current-Asset-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Soiken Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Soiken Holdings's Price-to-Net-Current-Asset-Value falls into.



Soiken Holdings Net Current Asset Value Calculation

Soiken Holdings's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Jun. 2023 is calculated as

Net Current Asset Value Per Share(A: Jun. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(7969.196-1067.766-203.362-0)/26.1582
=256.06

Soiken Holdings's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2024 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(6736.501-640.53-16.48-0)/26.1582
=232.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Soiken Holdings  (TSE:2385) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Soiken Holdings Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Soiken Holdings's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Soiken Holdings (TSE:2385) Business Description

Traded in Other Exchanges
N/A
Address
1-4-2 Shinsenri-Higashimachi, 13th Floor, Senri Life Science Center, Toyonaka, Osaka, JPN, 560-0082
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.

Soiken Holdings (TSE:2385) Headlines

No Headlines